Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Executive VP and COO acquired 150,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award SVP and CFO acquired 75,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy Director bought 300,000 shares at $3.08 ($923,130)
  10. 4 Grant or award President and CEO acquired 500,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 12,194 shares (grant or award)
  13. 4 Grant or award Director acquired 19,511 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 4,878 shares (grant or award)
  17. 4 Grant or award Director acquired 2,439 shares (grant or award)
  18. 4 Open-market buy Director bought 1,250,000 shares at $4.01 ($5,012,500)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 17 of 29 · 564 filings